Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Transarterial Chemoembolization in Combination With Immune Checkpoint Inhibitors for Hepatocellular Carcinoma: a Real-world Study

NCT04975932 is registered in ClinicalTrials.gov with Zhongda Hospital as lead sponsor.

NCT NCT04975932
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04975932 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Transarterial Chemoembolization in Combination With Immune Checkpoint Inhibitors for Hepatocellular Carcinoma: a Real-world Study
Lead sponsor
Zhongda Hospital
Phase
Observational
Overall status
Completed
Start date
July 1, 2021
Completion date
February 8, 2023
Enrollment
826 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma